Beyond Air, Inc. Common Stock (XAIR) Stock Price

XAIRStock

$2.16−95.63%52W

Market Cap$2.13M

P/E—

PEG Ratio—

Div yield—

Beta0.32

XAIR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-90.96%

Price vs S&P 500 (4W)-29.67%

VGM Score52.10

Book Value / Share (Quarterly)$2.69

P/TBV (Annual)1.42x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)62.09%

Cash Flow / Share (Quarterly)$-26.36

Price vs S&P 500 (YTD)-97.05%

Gross Margin (TTM)4.18%

Net Profit Margin (TTM)-435.71%

EPS (TTM)$-68.59

10-Day Avg Trading Volume0.05M

EPS Excl Extra (TTM)$-68.59

Revenue Growth (5Y)40.75%

EPS (Annual)$-80.11

ROI (Annual)-118.05%

Gross Margin (Annual)3.28%

Net Profit Margin (5Y Avg)-2190.49%

Cash / Share (Quarterly)$13.20

Revenue Growth QoQ (YoY)0.45%

ROA (Last FY)-93.96%

Revenue Growth TTM (YoY)60.75%

EBITD / Share (TTM)$-47.55

ROE (5Y Avg)-266.62%

Operating Margin (TTM)-368.90%

Cash Flow / Share (Annual)$-32.51

P/B Ratio1.37x

P/B Ratio (Quarterly)3.22x

Net Income / Employee (Annual)$-545,100

EV / Revenue (TTM)2.55x

Net Interest Coverage (TTM)-6.28x

ROA (TTM)-98.50%

EPS Incl Extra (Annual)$-80.11

Current Ratio (Annual)3.80x

Quick Ratio (Quarterly)2.38x

3-Month Avg Trading Volume0.16M

52-Week Price Return-95.63%

Revenue / Employee (TTM)$126,000

Tangible BV / Share (Quarterly)$1.39

P/S Ratio (Annual)0.36x

Asset Turnover (Annual)0.22x

52-Week High$53.20

Operating Margin (5Y Avg)-2198.85%

EPS Excl Extra (Annual)$-80.11

CapEx CAGR (5Y)2.86%

Tangible BV CAGR (5Y)-29.86%

26-Week Price Return-81.05%

Quick Ratio (Annual)2.83x

13-Week Price Return-61.29%

Total Debt / Equity (Annual)3.60x

Current Ratio (Quarterly)3.31x

Enterprise Value$19.63M

Revenue / Share Growth (5Y)173.54%

Asset Turnover (TTM)0.23x

Book Value / Share Growth (5Y)49.40%

Revenue / Employee (Annual)$125,900

Inventory Turnover (Annual)3.89x

Pretax Margin (Annual)-447.12%

Cash / Share (Annual)$19.74

3-Month Return Std Dev105.25%

Net Income / Employee (TTM)$-549,100

ROE (Last FY)-542.75%

Net Interest Coverage (Annual)-5.25x

EPS Basic Excl Extra (Annual)$-80.11

Receivables Turnover (TTM)7.91x

Total Debt / Equity (Quarterly)11.22x

EPS Incl Extra (TTM)$-68.59

ROI (TTM)-127.03%

P/S Ratio (TTM)0.36x

Pretax Margin (5Y Avg)-2275.57%

Revenue / Share (Annual)$18.50

Tangible BV / Share (Annual)$8.66

Price vs S&P 500 (52W)-111.16%

Year-to-Date Return-85.12%

5-Day Price Return-6.49%

EPS Normalized (Annual)$-80.11

ROA (5Y Avg)-95.91%

Net Profit Margin (Annual)-432.99%

Month-to-Date Return-21.74%

Cash Flow / Share (TTM)$-2.15

EBITD / Share (Annual)$-63.03

Operating Margin (Annual)-380.38%

LT Debt / Equity (Annual)3.53x

ROI (5Y Avg)-133.63%

LT Debt / Equity (Quarterly)11.10x

EPS Basic Excl Extra (TTM)$-68.59

P/TBV (Quarterly)6.23x

P/B Ratio (Annual)1.19x

Inventory Turnover (TTM)3.95x

Pretax Margin (TTM)-447.64%

Book Value / Share (Annual)$10.39

Price vs S&P 500 (13W)-63.98%

Beta0.32x

P/FCF (Annual)2.14x

Revenue / Share (TTM)$10.66

ROE (TTM)-462.50%

52-Week Low$2.05

vGradeB

gGradeB

mGradeF

vgmGradeC

XAIR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	—	-$11.00	—
Q1 2026	Jun 26, 2026	-$11.33	-$15.40	-35.88%(-$4.07)
Q4 2025	Feb 13, 2026	-$10.80	-$17.00	-57.41%(-$6.20)
Q2 2025	Aug 12, 2025	-$26.40	-$30.60	-15.91%(-$4.20)
Q1 2025	Jun 17, 2025	-$48.80	-$36.00	+26.23%(+$12.80)
Q4 2024	Feb 10, 2025	-$64.00	-$60.00	+6.25%(+$4.00)
Q3 2024	Nov 11, 2024	-$113.60	-$112.00	+1.41%(+$1.60)

XAIR Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

4.14

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
XAIRBeyond Air, Inc. Common Stock	B	B	F	0.4x	40.8%	4.2%	-368.9%	$2.16
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Beyond Air, Inc. Common Stock

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a proprietary nitric oxide (NO) generator and delivery system, extracting NO from ambient air for inhaled therapeutic treatment. The company is advancing its technology for pulmonary hypertension and lower respiratory tract infections.

XAIR Next Earnings Report

Report dateNov 10, 2026

QuarterQ3 2026

Report timeBMO

Revenue estimate$2.30M

Also reporting on Nov 10, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

APMAptorum Group Limited Class A Ordinary SharesMeasuring & Controlling Devices
FCUVFocus Universal Inc. Common StockIndustrial Instruments
POASPhaos Technology Holdings (Cayman) LimitedIndustrial Instruments
NXLNexalin Technology, Inc. Common StockElectromedical Equipment
NUWENuwellis, Inc. Common StockElectromedical Equipment
BBLGBone Biologics Corp Common StockOrthopedic & Prosthetic Devices
FEEDENvue Medical, Inc. Common StockOrthopedic & Prosthetic Devices
AVNSAvanos Medical, Inc.Orthopedic & Prosthetic Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$2.05

High$53.20